Late in August, Versanis Bio emerged as a new biotech startup with $70 million in funding to develop bimagrumab for obesity and metabolic disease
ALA supplementation suppresses SP1 and LXR in C57BL/6 mice that are fed an HFD or given LXR agonists
[97,110] Liraglutide also has reno-protective properties, making it suitable for patients with mild to moderate chronic kidney disease, although caution is necessary in advanced cases due to dehydration risks
In addition, in an attempt to have a dual drug-prodrug mechanism of action, a melatonin-SFN hybrid has been designed, which demonstrated to induce neuroprotection in cortical neurons subjected to OS [293]
Why Silencing Food Noise with GLP-1s Distracts From the Real Problem This edition covers: The definition of food noise and what causes it The role of GLP-1s in reducing food noise Why silencing food noise is a start but not a solution to obesity If youve been following the topic of GLP-1s in the media, youve likely heard of food noise (i.e